期刊文献+

肿瘤坏死因子相关凋亡诱导配体在外周血单个核细胞中的表达

Expression of TNF related apoptosis inducing ligand in peripheral blood mononuclear cells
下载PDF
导出
摘要 目的 :研究肿瘤坏死因子相关凋亡诱导配体 (TRAIL)在外周血单个核细胞 (PBMC)中的表达及其意义。方法 :用免疫组织化学的方法检测PBMC中TRAIL的表达情况。结果 :淋巴细胞分离液得到的PBMC中 ,淋巴细胞占 (97.4 8± 3.4 3) % ,单核细胞占 (3.15± 0 .83) % ,TRAIL免疫反应阳性的淋巴细胞占总数的 (2 6 .31± 3.18) % ,呈TRAIL免疫反应阳性的单核细胞占总数的(1.0 4± 0 .13) % ,TRAIL免疫反应阳性物质分布于胞质内 ,核呈阴性反应。结论 :正常人外周血分离的淋巴细胞及单核细胞有TRAIL表达。 Objective: To investigate the expressi on of TNF related apoptosis inducing ligand (TRAIL) in peripheral blood mononuclear cells. Methods: The PBMCs were obtained and purifed from healthy volunteers.Immunohistochemical staining was used to detect the TRAIL immunoreactive expression in PBMCs. Results: Some lymphocytes and monocytes in PBMCs showed TRAIL in immunoreactivity.The immunoreactive positive substance distributed in cytoplasma with negative nuclei. The rate of lymphocytes and monocytes with TRAIL immunoreactivity were (26.31±3.18)% and (1.04±0.13)%,respectively. Conclusion: These results suggest that TRAIL protein may be expressed in some lymphocytes and monocytes in PBMCs.
出处 《解剖学杂志》 CAS CSCD 北大核心 2005年第1期29-30,i004,共3页 Chinese Journal of Anatomy
关键词 TRAIL 表达 淋巴细胞 肿瘤坏死因子相关凋亡诱导配体 PBMC 外周血单个核细胞 单核细胞 总数 结论 目的 TNF related apoptosis inducing ligand peripheral blood mononuclear cells immunohistochemitry
  • 相关文献

参考文献8

  • 1季军捷,卫立辛,李晓东,吴孟超,郭亚军.激活淋巴细胞中TRAIL及其受体表达的初步研究[J].第二军医大学学报,2002,23(7):788-790. 被引量:2
  • 2Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science, 1997, 276 (5309): 111-113.
  • 3Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 1995, 270(5239): 1189-1192.
  • 4Wiley SR, Schodey k, Smolak D, et al. Identification and characterization of a new member of the TNF family that induces apoptosis .Immunity, 1995, (3) :673-682.
  • 5Nagata S. Apoptosis by death factor. Cell,1997, 88(3):355-365.
  • 6MacFarlane M, Ahmad M, Srinivasula SM, et al. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem, 1997,272(41 ): 25417-25420.
  • 7Kayagaki N, Yamaguchi N, Nakayama M, et al. Involvement of TNF-related apoptosis-inducing ligand in human CD4 +T cell-mediated cytotoxicity. J Immunol,1999, 162(5) :2639-2647.
  • 8Halaas O, Vik R, Ashkenazi A, et al. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand J Immunol,2000,51(3) :244-250.

二级参考文献8

  • 1[1]Scaffidi C, Kirchhoff S, Peter HE, et al. Apoptosis signaling in lymphocytes[J]. Curr Opin Immuno, 1999,11(3):277-285.
  • 2[2]Wiley SR, Schooley K, Smolak PG, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity,1995,3(6):673-682.
  • 3[3]Simonet WS,Laccy DL,Dunstan CR,et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell,1997,89(2):309-319.
  • 4[4]Emery JG, McDonnell P, Brigham BM, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL[J]. J Biol Chem,1998, 273(23):14363-14367.
  • 5[5]Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors[J]. Curr Opin Cell Biol, 1999,11(2):255-260.
  • 6[6]Ozawa F, Friess H, Kleeff J, et al. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer[J]. Cancer Lett, 2001,163(1):71-81.
  • 7[7]Nimmanapalli R, Perkins CL, Orlando M, et al. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels[J]. Cancer Res,2001,61(2):759-763.
  • 8[8]Jeremias I, Herr I, Boehler T, et al. TRAIL/Apo-2 ligand-induced apoptosis in human T cells[J]. Eur J Immunol, 1998,28(1):143-152.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部